Lv41
480 积分 2022-08-30 加入
Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR1 -Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups
1小时前
待确认
Disitamab Vedotin: First Approval
1个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
1个月前
已完结
Current status and future outlooks on therapeutic drug monitoring of fluorouracil
2个月前
已完结
Influence of methylene tetrahydrofolate reductase C667T gene polymorphism on survival time of adanced gastric cancer patients treated with 5-fluorouracil-based chemotherapy
2个月前
已完结
中国成人血脂异常防治指南（2016年修订版）亮点解读
2个月前
已完结
[Guidelines for prevention and treatment of postpartum hemorrhage (2023)]
5个月前
已完结
皖公网安备34019202002308
